Bipolar Affective Disorder Clinical Trial
Official title:
An Investigation Into the Safety, Acceptability and Feasibility of a Brief Compassion-Focused Intervention for People Who Experience Distressing Mood Swings: A Case Series.
Verified date | May 2023 |
Source | Institute of Psychiatry, London |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this case series is to investigate whether a brief compassion-focused intervention is a safe, acceptable and feasible therapy for clients with bipolar affective disorder. The secondary questions are whether a brief compassion focused intervention for BPD clients is associated with changes in bipolar mood symptoms and/ or with changes in psychological processes linked to mood symptoms in bipolar, including: Self-compassion, perfectionism, social comparison and social safeness. Four visual analogue scales will also be completed daily by each participant throughout the project. These scales will measure domains relevant to BPAD symptomology and self-compassion. Participants will complete a 4 session Compassion-Focused Therapy Intervention. The first session will involve completion of the psychoeducation and formulation work which was started during the initial assessment session. Each intervention session will also involve the introduction and practice of CFT techniques or exercises. The trial therapist will introduce the exercise and practice it together with the participant during the session. Participants will then be asked to continue practicing the exercises for homework. Their experience of the practice and any difficulties can then be discussed at the start of the next session.
Status | Recruiting |
Enrollment | 6 |
Est. completion date | June 9, 2023 |
Est. primary completion date | June 9, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adults (18 years and older) - Diagnosis of Bipolar Affective Disorder Exclusion Criteria: - Client considered to be actively at acute risk - judgement made by responsible clinical team and also by risk assessment at our first assessment session. High risk clients are excluded as due to time constraints it will be difficult to address risk issues and complete the intervention in the short time frame we have outlined. - Client already receiving some form of CFT intervention, as this be a potential confounder. - Level of English not strong enough to complete assessment and intervention sessions without use of interpreter. Again, due to time constraints it would be difficult to complete the intervention with clients in the timeframe outline whilst using an interpreter or navigating the language barrier. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Institute of Psychiatry, Psychology & Neuroscience | London |
Lead Sponsor | Collaborator |
---|---|
Institute of Psychiatry, London | South London and Maudsley NHS Foundation Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the Credibility and Expectancy Questionnaire (CEQ)(Devilly & Borkovec, 2000) | Assessment/Baseline Only | ||
Primary | Client Satisfaction Questionnaire (CSQ-8) (Larsen, Attkison, Hargreaves & Nguyen, 1979). | Follow-up (2 weeks post-intervention) | ||
Secondary | internal states scale (ISS) (Bauer, 1991) | Assessment (Baseline) and Follow-Up (2 weeks post intervention) | ||
Secondary | The Self Compassion Scale Short Form(SCS-SF) (Raes, Pommier, Neff & Van Gucht, 2011) | Assessment (Baseline) and Follow-Up (2 weeks post intervention) | ||
Secondary | The Short Revised Almost Perfect Scale (SAPS) (Rice, Richardson & Tueller, 2014) | Assessment (Baseline) and Follow-Up (2 weeks post intervention) | ||
Secondary | The Social Comparison Scale (Allan & Gilbert, 1995) | Assessment (Baseline) and Follow-Up (2 weeks post intervention) | ||
Secondary | The Social Safeness and Pleasure Scale (Gilbert et al, 2009) | Assessment (Baseline) and Follow-Up (2 weeks post intervention) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03275714 -
Evaluation of an App for Smartphones for People With a Bipolar Affective Disorder
|
N/A | |
Completed |
NCT03249857 -
Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder.
|
N/A | |
Completed |
NCT01722344 -
Improving Work Outcome for People With Severe Mental Illness
|
N/A | |
Completed |
NCT01431092 -
Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia
|
Phase 4 | |
Completed |
NCT01315028 -
Bipolar Intervention Study: Cognitive Interpersonal Therapy
|
N/A | |
Terminated |
NCT00805493 -
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
|
Phase 2 | |
Completed |
NCT00436020 -
rTMS in the Treatment of Bipolar Depression
|
N/A | |
Withdrawn |
NCT00397605 -
Cannabinoids in Bipolar Affective Disorder
|
N/A | |
Recruiting |
NCT06176456 -
Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia
|
N/A | |
Terminated |
NCT03310593 -
Cannabidiol as an Adjunctive Treatment for Bipolar Depression
|
Phase 2/Phase 3 | |
Recruiting |
NCT05406414 -
The Efficacy of a Transdiagnostic Sleep and Circadian Intervention for Patients With Mental Disorders and Sleep Problems
|
N/A | |
Completed |
NCT02773108 -
Somatic Comorbidities in Psychiatric Patients
|
||
Recruiting |
NCT00474357 -
Myths About Bipolar Affective Disorder: The Role of Structured Group Psychoeducation Therapy
|
N/A | |
Withdrawn |
NCT00327756 -
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder
|
Phase 2 | |
Completed |
NCT02453217 -
The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial
|
N/A | |
Completed |
NCT05683431 -
Using Neuroplasticity-Based Computerized Training to Improve Emotion Regulation in Bipolar Disorder (BRAINS)
|
N/A | |
Not yet recruiting |
NCT05915312 -
Exosome for Early Diagnosis of Bipolar Affective Disorder
|
||
Completed |
NCT00186758 -
Transcranial Magnetic Stimulation in Bipolar Depression
|
Phase 4 | |
Completed |
NCT02083978 -
Bipolar Research Study Using MR Imaging
|
N/A | |
Completed |
NCT00683709 -
Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder
|
Phase 4 |